Description
Schedule of activities for takeover offer of up to 4,17,45,264 equity shares of J B Chemicals & Pharmaceuticals Ltd at Rs. 1,639.18 per share from November 18 to December 1, 2025.
Summary
BSE has announced the schedule for the Offer to Buy – Acquisition Window (Takeover) for J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM). The offer is for up to 4,17,45,264 equity shares at Rs. 1,639.18 per share and will be conducted from November 18, 2025, to December 1, 2025. Trading members and custodian members must follow specified operational procedures using the iBBS platform and RTRMS for bid submissions.
Key Points
- Security Details: J B Chemicals & Pharmaceuticals Ltd (Symbol: JBCHEPHARM, ISIN: INE572A01036, Scrip Code: 506943)
- Offer Size: Up to 4,17,45,264 equity shares
- Offer Price: Rs. 1,639.18 per share
- Market Lot: 1 share
- Face Value: Rs. 1.00
- Bid Offering Period: November 18, 2025 (9:15 AM) to December 1, 2025 (3:30 PM)
- Give-up/Take-up Period: November 18-28, 2025 (9:15 AM to 3:30 PM)
- Last Day Give-up: December 1, 2025 (9:15 AM to 3:30 PM)
- Last Day Take-up: December 1, 2025 (9:15 AM to 4:00 PM)
- Eligible Investor Categories: FII, Financial Institutions, Mutual Funds, Insurance Companies, Other QIBs, Other NIB, Company, Individual
Regulatory Changes
No new regulatory changes introduced. This circular provides operational guidelines for the takeover offer following existing OTB framework established in Exchange Notices 20150930-1 (September 30, 2015) and 20170203-29 (February 3, 2017).
Compliance Requirements
- Trading Members: Must ensure investor UCC is registered/updated with correct PAN Number and Category in Exchange UCC database
- Bidding Eligibility: Members can only bid for investors having shares in demat form
- Platform Access: Members and custodians must use designated URLs:
- iBBS Platform (Internet): https://ibbs.bseindia.com/
- iBBS Platform (Leased Line): https://ibbsll.bseindia.com/
- RTRMS (Internet): https://rtrms.bseindia.com/
- RTRMS (Leased Line): https://rtrmsll.bseindia.com/
- Extranet (Internet): https://member.bseindia.com/
- Extranet (Leased Line): https://memberll.bseindia.com/
- File Availability: Files on Extranet for bid acceptance available only after confirmation from Merchant Banker/RTA post-issue closure
- No Acceptance Scenario: If no securities are accepted, no End of Issue files will be generated in Extranet
Important Dates
- Opening Date: Tuesday, November 18, 2025
- Closing Date: Monday, December 1, 2025
- Bid Offering Window: November 18 - December 1, 2025 (9:15 AM - 3:30 PM daily)
- Give-up/Take-up Period: November 18-28, 2025 (9:15 AM - 3:30 PM)
- Last Day for Give-up: December 1, 2025 (9:15 AM - 3:30 PM)
- Extended Take-up on Last Day: December 1, 2025 (9:15 AM - 4:00 PM)
Impact Assessment
Market Impact: Medium - The takeover offer affects a significant volume of shares (41.7 million) representing a material portion of J B Chemicals & Pharmaceuticals Ltd’s equity. The fixed offer price of Rs. 1,639.18 per share provides price certainty during the offer period.
Operational Impact: Trading members and custodians handling JBCHEPHARM shares must allocate resources for:
- Processing investor bids through iBBS platform
- Ensuring UCC database compliance
- Managing give-up/take-up transactions during specified windows
- Coordinating with investors holding shares in demat form
Investor Impact: Shareholders of JBCHEPHARM have a defined window to participate in the takeover offer at the specified price, subject to their shares being in demat form and proper UCC registration through their trading members.
Contact Support: BSE has provided dedicated support contacts for iBBS, RTRMS, and Extranet access issues, ensuring operational continuity during the offer period.
Impact Justification
Material corporate action affecting up to 41.7 million shares with specified takeover procedures for a listed pharmaceutical company